Laboratory Corp. Is Maintained at Equal-Weight by Barclays
Labcorp Holdings Analyst Ratings
Barclays Maintains Labcorp Holdings(LH.US) With Hold Rating, Cuts Target Price to $234
Barclays Sticks to Their Hold Rating for Laboratory (LH)
Morgan Stanley Maintains Labcorp Holdings(LH.US) With Buy Rating, Maintains Target Price $260
Labcorp Holdings Analyst Ratings
Piper Sandler Initiates Labcorp Holdings(LH.US) With Hold Rating, Announces Target Price $235
Evercore ISI Trims Price Target on Labcorp Holdings to $240 From $250, Keeps In Line Rating
Jefferies Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $265
Laboratory Corp. Is Maintained at Outperform by Baird
Labcorp Holdings Analyst Ratings
Baird Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $282
Baird Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $278
Baird Adjusts Price Target on Labcorp Holdings to $278 From $277, Maintains Outperform Rating
JPMorgan Adjusts Price Target on Labcorp Holdings to $271 From $243, Maintains Overweight Rating
Argus Raises Laboratory Corp of America's Price Target to $260 From $250
Mizuho Securities Maintains Labcorp Holdings(LH.US) With Buy Rating
Labcorp Holdings Analyst Ratings
BofA Securities Maintains Labcorp Holdings(LH.US) With Buy Rating, Raises Target Price to $260
Laboratory Corp. Price Target Raised to $249.00/Share From $213.00 by Barclays